Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review

M Daliri, TP Johnston, A Sahebkar - Journal of Pharmacy and …, 2023 - academic.oup.com
Objectives Peripheral neuropathy (PN), as an adverse reaction attributed to statin drugs, as
well as the beneficial neuroprotective properties of statins, have been widely reported and …

Cholesterol Management in Neurology: Time for Revised Strategies?

FL Andronie-Cioară, A Jurcău, MC Jurcău… - Journal of Personalized …, 2022 - mdpi.com
Statin therapy has been extensively evaluated and shown to reduce the incidence of new or
recurrent vascular events, ischemic stroke included. As a consequence, each published …

Simvastatin accelerated motoneurons death in SOD1G93A mice through inhibiting Rab7-mediated maturation of late autophagic vacuoles

L Bai, Y Wang, J Huo, S Li, Y Wen, Q Liu, J Yang… - Cell Death & …, 2021 - nature.com
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease caused by
motoneuron loss, for which there is currently no effective treatment. Statins, as inhibitors of 3 …

Statin protects men but not women with HIV against loss of muscle mass, strength, and physical function: a pilot study

JDG Cárdenas, VHF Oliveira, AL Borsari… - Scientific reports, 2023 - nature.com
Statins are cholesterol-lowering drugs commonly used among people with HIV, associated
with an increased risk of myopathies. Considering that cardiovascular disease, statin …

[HTML][HTML] MicroRNA-206 as a Potential Cholesterol-lowering Drug is Superior to Statins in Mice

C Li, J Tian, N Liu, D Song, CJ Steer, Q Han… - Journal of Lipid …, 2024 - Elsevier
Hypercholesterolemia is frequently intertwined with hepatosteatosis, hypertriglyceridemia,
and hyperglycemia. This study is designed to assess the therapeutic efficacy of miR-206 in …

Targeting EBV‐encoded products: Implications for drug development in EBV‐associated diseases

M Lv, Y Ding, Y Zhang, S Liu - Reviews in Medical Virology, 2024 - Wiley Online Library
Epstein‐Barr virus, a human gamma‐herpesvirus, has a close connection to the
pathogenesis of cancers and other diseases, which are a burden for public health …

[HTML][HTML] Guidelines for dyslipidemia management in India: A review of the current scenario and gaps in research

S Misra, T Lyngdoh, R Mulchandani - Indian heart journal, 2022 - Elsevier
Cardiovascular Diseases (CVD) have a high disease burden in India. Dyslipidemia, a major
CVD risk factor, requires effective management. Our review describes the appropriateness …

Delipid extracorporeal lipoprotein filter from plasma system: a new intensive lipid lowering therapy for patients with acute ischemic stroke

Y Jiao, Q Yang, T Ye, J Zhu, Q Li, X Han… - Frontiers in …, 2024 - frontiersin.org
Objectives To investigate the safety and efficacy of the delipid extracorporeal lipoprotein
filter from plasma (DELP) system, a new low-density lipoprotein cholesterol (LDL-C) …

Chinese Expert Consensus on the Clinical Diagnosis and Management of Statin Intolerance

JJ Li, KF Dou, ZG Zhou, D Zhao, P Ye… - Clinical …, 2024 - Wiley Online Library
The clinical benefits of statins have well‐established and recognized worldwide. Although
statins are well‐tolerated generally, however, the report of statin‐related adverse event and …

Major Genetic Drivers of Statin Treatment Response in African Populations and Pharmacogenetics of Dyslipidemia Through a One Health Lens

Z Lusiki, D Blom, ND Soko, S Malema… - OMICS: A Journal of …, 2023 - liebertpub.com
A One Health lens is increasingly significant to address the intertwined challenges in
planetary health concerned with the health of humans, nonhuman animals, plants, and …